Micro Syringes Segmentation
Needle Type (Fixed, Removable)
The removable sub-segment in the needle type segment is predicted to dominate over 65% market share by the end of 2037. Removable needles are reusable in nature and it is available in different sizes. They are also available in different customizations and different point styles. Owing to all such qualities, they are widely preferred by inexperienced users.
End-User (Biotechnological Laboratories, Biotechnological & Pharmaceutical Industry, Research Institutes, Hospitals)
The laboratories segment with a share of 35% is poised to lead the market of micro syringes by 2037. This is attributed to the increasing laboratory research activities throughout the globe and the increasing usage of micro syringes in laboratories for drawing up and expelling liquids or suspensions facilitating such research works.
Our in-depth analysis of the global market includes the following segments:
|
Type |
|
|
Needle Type |
|
|
End User |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
2025 Micro Syringes Market is evaluated at USD 360.47 million.
The global micro syringes market size exceeded USD 341.87 million in 2024 and is projected to expand at a CAGR of more than 6.8%, crossing USD 804.06 million by 2037.
North America is expected to grow to USD 281.42 million by 2037, fueled by the U.S.'s dominance in pharmaceutical spending and rising R&D activities.
The major players in the market are Trajan Scientific and Medical, Thermo Fisher Scientific Inc., Innovative Labor Systeme GmbH (ILS), GL Science, Inc., PerkinElmer, Inc., Agilent Technologies, Inc., Shimadzu Corporation, Avantor, Inc., ITO Corporation, Merck KGaA
